Illinois Municipal Retirement Fund grew its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 2.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 312,818 shares of the company’s stock after acquiring an additional 6,521 shares during the period. Illinois Municipal Retirement Fund’s holdings in Colgate-Palmolive were worth $24,719,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. CBIZ Investment Advisory Services LLC raised its position in Colgate-Palmolive by 86.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after purchasing an additional 150 shares during the period. Maseco LLP purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $27,000. Global Wealth Strategies & Associates grew its stake in shares of Colgate-Palmolive by 300.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after buying an additional 300 shares in the last quarter. Grove Bank & Trust grew its stake in shares of Colgate-Palmolive by 182.6% in the fourth quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after buying an additional 263 shares in the last quarter. Finally, Camelot Portfolios LLC acquired a new position in Colgate-Palmolive during the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on CL shares. Bank of America lowered their price objective on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Piper Sandler decreased their price objective on shares of Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Colgate-Palmolive in a research note on Friday, May 1st. Twelve equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.88.
Colgate-Palmolive Stock Performance
Shares of CL stock opened at $89.91 on Thursday. The stock has a market capitalization of $71.94 billion, a price-to-earnings ratio of 34.98, a PEG ratio of 4.56 and a beta of 0.33. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company’s 50-day simple moving average is $86.68 and its 200-day simple moving average is $86.17. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. During the same period in the previous year, the company earned $0.91 earnings per share. Colgate-Palmolive’s quarterly revenue was up 8.4% on a year-over-year basis. Equities analysts anticipate that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.
Colgate-Palmolive Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Read More
- Five stocks we like better than Colgate-Palmolive
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
